176 related articles for article (PubMed ID: 37989822)
1. Anoikis patterns via machine learning strategy and experimental verification exhibit distinct prognostic and immune landscapes in melanoma.
Liu J; Ma R; Chen S; Lai Y; Liu G
Clin Transl Oncol; 2024 May; 26(5):1170-1186. PubMed ID: 37989822
[TBL] [Abstract][Full Text] [Related]
2. Identification of hub anoikis-associated genes and risk signature in cutaneous melanoma.
He YW; Fan QP; Hua AL; Liu Q
Eur Rev Med Pharmacol Sci; 2023 Jun; 27(12):5662-5676. PubMed ID: 37401304
[TBL] [Abstract][Full Text] [Related]
3. Development of a biomarker signature associated with anoikis to predict prognosis and immunotherapy response in melanoma.
Wu Z; Zhang R; Bao J; Yin M; Wang X
Arch Dermatol Res; 2024 May; 316(6):219. PubMed ID: 38787413
[TBL] [Abstract][Full Text] [Related]
4. Identification of anoikis-related genes classification patterns and immune infiltration characterization in ischemic stroke based on machine learning.
Qin X; Yi S; Rong J; Lu H; Ji B; Zhang W; Ding R; Wu L; Chen Z
Front Aging Neurosci; 2023; 15():1142163. PubMed ID: 37032832
[TBL] [Abstract][Full Text] [Related]
5. Identification of anoikis-related subtypes and development of risk stratification system in skin cutaneous melanoma.
Tian J; Cao ZJ; Zhang Y; Zhou JK; Yang L
Heliyon; 2023 May; 9(5):e16153. PubMed ID: 37215879
[TBL] [Abstract][Full Text] [Related]
6. Identification and verification of a novel anoikis-related gene signature with prognostic significance in clear cell renal cell carcinoma.
He Z; Gu Y; Yang H; Fu Q; Zhao M; Xie Y; Liu Y; Du W
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11661-11678. PubMed ID: 37402968
[TBL] [Abstract][Full Text] [Related]
7. Identification of anoikis related subtypes and construction of prognostic model in hepatocellular carcinoma.
Fang W; Chen Z
Cell Mol Biol (Noisy-le-grand); 2023 Sep; 69(9):219-228. PubMed ID: 37807308
[TBL] [Abstract][Full Text] [Related]
8. Predicting the clinical outcome of melanoma using an immune-related gene pairs signature.
Meng L; He X; Zhang X; Zhang X; Wei Y; Wu B; Li W; Li J; Xiao Y
PLoS One; 2020; 15(10):e0240331. PubMed ID: 33031392
[TBL] [Abstract][Full Text] [Related]
9. A novel stratification framework based on anoikis-related genes for predicting the prognosis in patients with osteosarcoma.
Zhang X; Wen Z; Wang Q; Ren L; Zhao S
Front Immunol; 2023; 14():1199869. PubMed ID: 37575253
[TBL] [Abstract][Full Text] [Related]
10. Identification and Validation of Anoikis-Related Signatures for Predicting Prognosis in Lung Adenocarcinoma with Machine Learning.
Wang Q; Sun N; Zhang M
Int J Gen Med; 2023; 16():1833-1844. PubMed ID: 37213475
[TBL] [Abstract][Full Text] [Related]
11. Identification and validation of an anoikis-related lncRNA signature to predict prognosis and immune landscape in osteosarcoma.
Zhang JS; Pan RS; Tian XB
Front Oncol; 2023; 13():1156663. PubMed ID: 37035149
[TBL] [Abstract][Full Text] [Related]
12. Construction of anoikis-related lncRNAs risk model: Predicts prognosis and immunotherapy response for gastric adenocarcinoma patients.
Li Q; Zhang H; Hu J; Zhang L; Zhao A; Feng H
Front Pharmacol; 2023; 14():1124262. PubMed ID: 36925640
[No Abstract] [Full Text] [Related]
13. An anoikis-related gene signature predicts prognosis and reveals immune infiltration in hepatocellular carcinoma.
Chen Y; Lin QX; Xu YT; Qian FJ; Lin CJ; Zhao WY; Huang JR; Tian L; Gu DN
Front Oncol; 2023; 13():1158605. PubMed ID: 37182175
[TBL] [Abstract][Full Text] [Related]
14. A novel immune checkpoint-related seven-gene signature for predicting prognosis and immunotherapy response in melanoma.
Tian M; Yang J; Han J; He J; Liao W
Int Immunopharmacol; 2020 Oct; 87():106821. PubMed ID: 32731180
[TBL] [Abstract][Full Text] [Related]
15. Autophagy-related long non-coding RNA prognostic model predicts prognosis and survival of melanoma patients.
Qiu Y; Wang HT; Zheng XF; Huang X; Meng JZ; Huang JP; Wen ZP; Yao J
World J Clin Cases; 2022 Apr; 10(11):3334-3351. PubMed ID: 35611195
[TBL] [Abstract][Full Text] [Related]
16. A novel anoikis-related gene signature to predict the prognosis, immune infiltration, and therapeutic outcome of lung adenocarcinoma.
Wang Y; Xie C; Su Y
J Thorac Dis; 2023 Mar; 15(3):1335-1352. PubMed ID: 37065587
[TBL] [Abstract][Full Text] [Related]
17. Integrative transcriptional characterization of cell cycle checkpoint genes promotes clinical management and precision medicine in bladder carcinoma.
Shi WW; Guan JZ; Long YP; Song Q; Xiong Q; Qin BY; Ma ZQ; Hu Y; Yang B
Front Oncol; 2022; 12():915662. PubMed ID: 36033441
[TBL] [Abstract][Full Text] [Related]
18. Genome-wide screening and immune landscape suggest a potential-m6A-related lncRNA risk signature for predicting prognosis of melanoma.
Shen K; Wang H; Xue S; Wang L; Ren M; Gao Z; Wei C; Gu J
Ann Transl Med; 2022 Mar; 10(5):241. PubMed ID: 35402579
[TBL] [Abstract][Full Text] [Related]
19. Development of a novel, clinically relevant anoikis-related gene signature to forecast prognosis in patients with prostate cancer.
Liu X; Wang K
Front Genet; 2023; 14():1166668. PubMed ID: 37719710
[No Abstract] [Full Text] [Related]
20. Prognostic model for hepatocellular carcinoma based on anoikis-related genes: immune landscape analysis and prediction of drug sensitivity.
Zhang D; Liu S; Wu Q; Ma Y; Zhou S; Liu Z; Sun W; Lu Z
Front Med (Lausanne); 2023; 10():1232814. PubMed ID: 37502362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
